AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26861924 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441
Study 26861924 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 1441
Study 25197999 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal and visual education
Number of subjects: 54
Study 25197999 — intervention group
Group type: COMPARATOR
Intervention: Verbal education
Number of subjects: 54
Study 22721455 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (triamcinolone acetonide)
Number of subjects: 100
Study 22721455 — intervention group
Group type: COMPARATOR
Intervention: NSAID injection (diclofenac sodium)
Number of subjects: 100
Study 19672733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - oral 0.625 mg conjugated estrogen + 2.5 mg medroxyprogesterone acetate/day for 3 and 6 months
Number of subjects: 60
Study 19672733 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HRT)
Number of subjects: 60
Study 17377770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fish oil fat emulsion (0.5 g/kg 10% emulsion, Omegaven) administered twice, 48 and 24 hours before investigation.
Number of subjects: 16
Study 17377770 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 16
Study 16276692 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg daily
Number of subjects: 0
Study 16276692 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate 400 microg twice daily
Number of subjects: 0
Study 12042011 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug therapy (amiodarone, propafenone, flecainide, sotalol)
Number of subjects: 68
Study 12042011 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic drug therapy
Number of subjects: 68
Study 12042011 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug therapy
Number of subjects: 68
Study 10213329 — intervention group
Group type: EXPERIMENTAL
Intervention: Propiverine 15 mg t.i.d.
Number of subjects: 113
Study 10213329 — intervention group
Group type: COMPARATOR
Intervention: Placebo t.i.d.
Number of subjects: 113
Study 7606516 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium, 4 mg aerosol 30 min before challenge
Number of subjects: 21
Study 7606516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 2206227 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple drug treatment (azathioprine, cyclosporin, methylprednisolone)
Number of subjects: 128
Study 2206227 — intervention group
Group type: COMPARATOR
Intervention: Aza and MP (group A)
Number of subjects: 128
Study 2206227 — intervention group
Group type: COMPARATOR
Intervention: CyA monotherapy (group B)
Number of subjects: 128
Study 2206227 — intervention group
Group type: COMPARATOR
Intervention: CyA and MP (group C)
Number of subjects: 128
Study 2206227 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple drug treatment
Number of subjects: 128
Study 2206227 — intervention group
Group type: COMPARATOR
Intervention: Aza and MP, CyA monotherapy, CyA and MP (controls)
Number of subjects: 128
Study 400933 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (2.0 g intramuscularly with 1.0 g of oral probenecid)
Number of subjects: 143
Study 400933 — intervention group
Group type: COMPARATOR
Intervention: Aqueous procaine penicillin G (4.8 x 10(6) units intramuscularly with 1.0 g of oral probenecid)
Number of subjects: 143
Study 400933 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 143
Study 31256715 — intervention group
Group type: EXPERIMENTAL
Intervention: Various lifejacket designs trialed with lobstermen, nine designs were tested during winter and summer fishing seasons.
Number of subjects: 181
Study 29095006 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity program in the aquatic environment (SWEP method)
Number of subjects: 140
Study 29095006 — intervention group
Group type: COMPARATOR
Intervention: Sedentary women (Control group)
Number of subjects: 140
Study 26494629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax AWS
Number of subjects: 67
Study 26494629 — intervention group
Group type: COMPARATOR
Intervention: Airtraq
Number of subjects: 67
Study 26494629 — intervention group
Group type: COMPARATOR
Intervention: McCoy
Number of subjects: 67
Study 24309749 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisensory stimulation (audiotactile)
Number of subjects: 36
Study 23048052 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3798
Study 23048052 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 3798
Study 19741492 — intervention group
Group type: EXPERIMENTAL
Intervention: Early epidural (cervical dilation at least 1.0 cm)
Number of subjects: 12793
Study 19741492 — intervention group
Group type: COMPARATOR
Intervention: Delayed epidural (cervical dilation at least 4.0 cm)
Number of subjects: 12793
Study 17889772 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR6D SE IOL (angulated)
Number of subjects: 44
Study 17889772 — intervention group
Group type: COMPARATOR
Intervention: C‐flex 570C IOL (nonangulated)
Number of subjects: 44
Study 15200541 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine irrigation through the axillary wound drain 4-hourly for 24 h postoperatively
Number of subjects: 100
Study 15200541 — intervention group
Group type: COMPARATOR
Intervention: Normal saline irrigation through the axillary wound drain
Number of subjects: 100
Study 12047399 — intervention group
Group type: EXPERIMENTAL
Intervention: glyburide/metformin 1.25/250 mg
Number of subjects: 806
Study 12047399 — intervention group
Group type: EXPERIMENTAL
Intervention: glyburide/metformin 2.5/500 mg
Number of subjects: 806
Study 12047399 — intervention group
Group type: EXPERIMENTAL
Intervention: glyburide/metformin (both doses)
Number of subjects: 806
Study 9524979 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 12
Study 9524979 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 12
Study 9524979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2059756 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX 10 mg/m2) given on days 1, 3, and 6, and daily cyclosporine (CSP) on days -1 through 180
Number of subjects: 34
Study 2059756 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning regimen with mild toxicity
Number of subjects: 34
Study 2059756 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning regimen with moderate toxicity
Number of subjects: 34
Study 2059756 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning regimen with severe toxicity
Number of subjects: 34
Study 2059756 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of MTX and daily CSP
Number of subjects: 34
Study 6841304 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir, 10 and 15 mg/kg 8 hourly, given as an iv bolus or iv infusion over 1 h for up to 7 days
Number of subjects: 6
Study 6841304 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir, 10 and 15 mg/kg 8 hourly, given as an iv bolus
Number of subjects: 6
Study 6841304 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir, high dosage by iv bolus mode of administration
Number of subjects: 6
Study 6841304 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir, 15 mg/kg 8‐hourly
Number of subjects: 6
Study 29931570 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical low-coherence reflectometry (OLCR) biometry
Number of subjects: 102
Study 30058646 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral CoQ10 supplementation
Number of subjects: 36
Study 30058646 — intervention group
Group type: EXPERIMENTAL
Intervention: Precooling strategy
Number of subjects: 36
Study 30058646 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with precooling
Number of subjects: 36
Study 30058646 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 26177791 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 70 mg weekly for 48 weeks
Number of subjects: 82
Study 26177791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 26177791 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (ALN)
Number of subjects: 82
Study 26177791 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline 25(OH)D < 32 ng/mL
Number of subjects: 82
Study 25153957 — intervention group
Group type: EXPERIMENTAL
Intervention: Han participants
Number of subjects: 128
Study 25153957 — intervention group
Group type: COMPARATOR
Intervention: Tibetan participants
Number of subjects: 128
Study 23342876 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategy 1: 1 of 3 criteria (inflammatory back pain, HLA‐B27, sacroiliitis on imaging)
Number of subjects: 141
Study 23342876 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategy 2: 2 of 6 criteria (IBP inflammatory back pain, HLA‐B27, sacroiliitis, family history, good response to NSAIDs, extra‐articular manifestations)
Number of subjects: 141
Study 20150883 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz real-rTMS of the SI cortex for 30 minutes daily for 5 days
Number of subjects: 20
Study 20150883 — intervention group
Group type: COMPARATOR
Intervention: Sham-rTMS
Number of subjects: 20
Study 18277063 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 36
Study 18277063 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise
Number of subjects: 36
Study 18277063 — intervention group
Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 36
Study 16188715 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy (eight sessions of cognitive behavioral therapy) plus pharmacotherapy (citalopram)
Number of subjects: 109
Study 16188715 — intervention group
Group type: COMPARATOR
Intervention: Assessment only condition
Number of subjects: 109
Study 16188715 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 109
Study 12885836 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard timing chemotherapy (DCTER: dexamethasone, cytarabine arabinoside, 6‐thioguanine, etoposide, daunorubicin)
Number of subjects: 161
Study 12885836 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard timing chemotherapy (DCTER)
Number of subjects: 161
Study 10883766 — intervention group
Group type: EXPERIMENTAL
Intervention: Tone of voice
Number of subjects: 182
Study 10883766 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal content
Number of subjects: 182
Study 9322463 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms plus dextrose 7.5%
Number of subjects: 66
Study 9322463 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil 10 micrograms plus saline
Number of subjects: 66
Study 9322463 — intervention group
Group type: COMPARATOR
Intervention: Plain dextrose 7.5%
Number of subjects: 66
Study 8458774 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (3 mg intravenous infusion)
Number of subjects: 12
Study 8458774 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study 2429117 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (200 micrograms as a single dose)
Number of subjects: 12
Study 2429117 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic administration of clonidine (200 micrograms twice a day for 3 weeks)
Number of subjects: 12
Study 2429117 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic administration of clonidine (400 micrograms twice a day for 6 weeks)
Number of subjects: 12
Study 30439315 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort analgesic sedative scheme with immediate analgesia and sedation score, CPOT 0-1 and RASS -1-0.
Number of subjects: 80
Study 30439315 — intervention group
Group type: COMPARATOR
Intervention: Daily analgesic and sedation regimen with CPOT 0-3 and RASS maintained at -3 to -4.
Number of subjects: 80
Study 26428903 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Velocity (HV) quadriceps exercises
Number of subjects: 21
Study 26428903 — intervention group
Group type: COMPARATOR
Intervention: Slow-Velocity (SV) quadriceps exercises
Number of subjects: 21
Study 24856942 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance foot and ankle exercise programme (HIGH)
Number of subjects: 60
Study 24856942 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity foot and ankle exercise control programme (LOW)
Number of subjects: 60
Study 22548261 — intervention group
Group type: EXPERIMENTAL
Intervention: Research network support
Number of subjects: 9
Study 22548261 — intervention group
Group type: EXPERIMENTAL
Intervention: CSOs involvement
Number of subjects: 9
Study 22548261 — intervention group
Group type: EXPERIMENTAL
Intervention: Research network contribution
Number of subjects: 9
Study 19945740 — intervention group
Group type: EXPERIMENTAL
Intervention: Six cycles of chemotherapy
Number of subjects: 427
Study 19945740 — intervention group
Group type: COMPARATOR
Intervention: Three cycles of chemotherapy
Number of subjects: 427
Study 18541764 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria rapid diagnostic tests (RDTs) in high transmission district
Number of subjects: 0
Study 18541764 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria rapid diagnostic tests (RDTs) in low transmission district
Number of subjects: 0
Study 18541764 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to revised clinical practices with RDTs
Number of subjects: 0
Study 15790990 — intervention group
Group type: EXPERIMENTAL
Intervention: Coughing up phlegm in winter mornings
Number of subjects: 14458
Study 15790990 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlegm at any time of the day in winter
Number of subjects: 14458
Study 15790990 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheeze or whistling from the chest
Number of subjects: 14458
Study 11788634 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene hydrochloride (RLX)
Number of subjects: 30
Study 11788634 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study 9873157 — intervention group
Group type: EXPERIMENTAL
Intervention: Older stroke patients (over 75 years)
Number of subjects: 296
Study 9873157 — intervention group
Group type: COMPARATOR
Intervention: Younger stroke patients (up to 75 years)
Number of subjects: 296
Study 7781864 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptorelin (n = 30)
Number of subjects: 55
Study 7781864 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (n = 25)
Number of subjects: 55
Study 1754636 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory stimulation during each REM sleep episode (Group R)
Number of subjects: 3
Study 1754636 — intervention group
Group type: COMPARATOR
Intervention: Auditory stimulation at the end of each REM sleep episode (Group NR)
Number of subjects: 3
Study 1754636 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory stimulation during each REM sleep period (Group D)
Number of subjects: 3
Study 7200653 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical instillation of adriamycin
Number of subjects: 0
Study 31119610 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider self-disclosure
Number of subjects: 882
Study 31119610 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-patient race concordance (Black concordant dyad)
Number of subjects: 882
Study 27333382 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (15 mg/kg/day for 12 months)
Number of subjects: 46
Study 27333382 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 46
Study 27577267 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychoeducation (four sessions of manualized family psychoeducation)
Number of subjects: 100
Study 27577267 — intervention group
Group type: COMPARATOR
Intervention: Social support (four sessions in a social support group led by a health care professional)
Number of subjects: 100
Study 27577267 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychoeducation
Number of subjects: 100
Study 27577267 — intervention group
Group type: COMPARATOR
Intervention: Social support
Number of subjects: 100
Study 24165473 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic bridging
Number of subjects: 0
Study 24165473 — intervention group
Group type: COMPARATOR
Intervention: Open Rives repair
Number of subjects: 0
Study 21233492 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical laryngoscope
Number of subjects: 60
Study 21233492 — intervention group
Group type: COMPARATOR
Intervention: Rigid laryngoscope
Number of subjects: 60
Study 19145529 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 30
Study 19145529 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 30
Study 17720098 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma tocopherol (308 mg) and DHA (800 mg)
Number of subjects: 70
Study 17720098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 15161110 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease supplementation (two tablets containing 325 mg pancreatic enzymes, 75 mg trypsin, 50 mg papain, 50 mg bromelain, 10 mg amylase, 10 mg lipase, 10 mg lysozyme, 2 mg chymotrypsin) four times a day for 4 days starting 1 day before exercise
Number of subjects: 20
Study 15161110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11800415 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine 20 mg orally every 8 hours during hospitalization
Number of subjects: 55
Study 11800415 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional treatment only)
Number of subjects: 55
Study 9654632 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 35
Study 9654632 — intervention group
Group type: COMPARATOR
Intervention: No TPN
Number of subjects: 35
Study 7979533 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive smoking exposure (measured by urinary cotinine concentration)
Number of subjects: 57
Study 7979533 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive smoking exposure (measured by parental smoking)
Number of subjects: 57
Study 7979533 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=51)
Number of subjects: 57
Study 2610721 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 200 mg naftidrofuryl
Number of subjects: 10
Study 2610721 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10
Study 30647436 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg phospholipid curcumin, one capsule per day for 8 weeks
Number of subjects: 58
Study 30647436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 29061728 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupler implantation and continuing previous pharmacotherapy
Number of subjects: 39
Study 29061728 — intervention group
Group type: COMPARATOR
Intervention: Previous treatment alone
Number of subjects: 39
Study 26867335 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual cycle and dual channel treatment (Group B)
Number of subjects: 60
Study 26867335 — intervention group
Group type: COMPARATOR
Intervention: Conventional single cycle treatment (Group A)
Number of subjects: 60
Study 23280147 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit pre-training instruction
Number of subjects: 0
Study 23280147 — intervention group
Group type: COMPARATOR
Intervention: Control (no explicit pre-training instruction)
Number of subjects: 0
Study 21931204 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg, one tablet every 6 hours for three days
Number of subjects: 30
Study 21931204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 18240965 — intervention group
Group type: EXPERIMENTAL
Intervention: ENF + OB
Number of subjects: 100
Study 18240965 — intervention group
Group type: COMPARATOR
Intervention: OB
Number of subjects: 100
Study 16644432 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiographic recordings of mitral annulus motion
Number of subjects: 24
Study 12801493 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular therapy using magnetic pearls
Number of subjects: 15
Study 10826459 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily for 5 days followed by 400 mg twice daily for 5 days
Number of subjects: 29
Study 10826459 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily for 10 days
Number of subjects: 29
Study 10826459 — intervention group
Group type: EXPERIMENTAL
Intervention: Both celecoxib and naproxen
Number of subjects: 29
Study 8925979 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam
Number of subjects: 56
Study 8925979 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin and Gentamicin
Number of subjects: 56
Study 2053097 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia
Number of subjects: 196
Study 2053097 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoas compartment block with additional inhalation anaesthesia
Number of subjects: 196
Study 2053097 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 196
Study 2053097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 2053097 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoas compartment block
Number of subjects: 196
Study 7032347 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 5 microgram/kg body weight before induction with thiopentone and suxamethonium
Number of subjects: 0
Study 7032347 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 0
Study 31776637 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg once every 6 months)
Number of subjects: 2850
Study 31776637 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 2850
Study 31776637 — intervention group
Group type: COMPARATOR
Intervention: Bisphosphonate (oral alendronate, risedronate, ibandronate, or intravenous zoledronic acid)
Number of subjects: 2850
Study 31776637 — intervention group
Group type: COMPARATOR
Intervention: Denosumab and Bisphosphonate
Number of subjects: 2850
Study 31014283 — intervention group
Group type: EXPERIMENTAL
Intervention: LASIK with 0.02% MMC application for 10 seconds
Number of subjects: 68